373110 fundamentals
An in-depth look to XCELL THERAPEUTICS INC. operating, investing, and financing activities
373110 free cash flow for Q3 24 is -2.77 B KRW. For 2023, 373110 free cash flow was -7.01 B KRW and operating cash flow was -6.78 B KRW.
Q1 '23
Q2 '23
Q3 '23
Q1 '24
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: KRW
Q1 '23
Q2 '23
Q3 '23
Q1 '24
Q2 '24
Q3 '24
TTM